Bioprotonics, Inc

bioProtonics’ µTexture in vivo, MR-based diagnostic provides the resolving power needed to measure the ultra fine tissue changes that are the earliest harbingers of disease, thus enabling most effective application of therapeutics. µTexture is: Clinically robust—works in the “real world” Fits seamlessly into MRI radiology workflow One minute added sequence Software implementation no expensive hardware required Readily operable by any scan technician